Explore all of ul.com

The US Food and Drug Administration (FDA) has updated their product-specific guidance for generic drug development.

This guide aims to facilitate generic drug product availability and to assist the generic pharmaceutical industry with identifying the most appropriate methodology for developing drugs and generating evidence needed to support ANDA approval.

This list is being updated on a regularly basis. For October 2017, 33 new and 19 revised guidances were made.



Subscribe to Newsletter

The CRS monthly Newsletter focuses on the latest initiatives, insights and information for manufacturers and retailers across industries.